数字健康技术应用于肿瘤患者化疗间歇期症状管理的范围综述

A Review of the Scope of Digital Health Technologies Applied to Symptom Management during the Chemotherapy Intervals of Cancer Patients

摘要: 目的：系统梳理数字健康技术在肿瘤患者化疗间歇期症状管理中的应用现状，以期为未来相关研究与实践提供参考。方法：系统检索数据库，检索时限为建库至2026年2月1日，汇总分析纳入文献。结果：最终纳入文献25篇，数字健康技术载体形式主要包括单一应用程序、数字健康平台及互联网设备联合应用程序，干预内容涵盖数据监测、智能预警、个性化指导、任务管理及互动交流。评价指标集中于七大方面，其中化疗相关症状、毒性改善及生活质量提升为核心。结论：数字健康技术能实现化疗间歇期症状的主动、个性化管理，具有积极应用效果。未来应构建覆盖诊疗全流程的一体化智能管理体系，在注重干预个性化的同时拓展适用人群，并着力突破关键技术障碍与数据安全挑战。此外，还需通过多中心、长期随访的高质量研究，进一步验证其长期效益与成本效益。

Abstract: Objective: To systematically review the current application of digital health technologies in symptom management for cancer patients during chemotherapy intervals, aiming to provide references for future research and practice. Methods: Systematic searches were conducted in databases from their inception to February 1, 2026. The included literature was summarized and analyzed. Results: A total of 25 studies were included. Digital health technologies primarily utilized single applications, digital health platforms, or internet-connected devices combined with applications. Interventions encompassed data monitoring, intelligent early warning, personalized guidance, task management, and interactive communication. Evaluation indicators focused on seven key aspects, with chemotherapy-related symptoms, toxicity reduction, and quality of life improvement as the core metrics. Conclusion: Digital health technologies can achieve proactive and personalized management of symptoms during chemotherapy breaks, and have positive application effects. In the future, an integrated intelligent management system covering the entire process of diagnosis and treatment should be established. Attention should be paid to individualized intervention while expanding the applicable population, and efforts should be made to break through key technical barriers and data security challenges. In addition, high-quality research through multi-center and long-term follow-up should be conducted to further verify its long-term benefits and cost-effectiveness.